Labisto, Roy A.

HRN: 27-36-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CLINDAMYCIN 300MG (CAP)
06/20/2025
06/27/2025
PO
300mg
Q6h
CELLULITIS
Remove - Pending Acceptance
06/20/2025
CEFTRIAXONE 1G (VIAL)
06/20/2025
06/27/2025
IV
2gm
OD
CELLULITIS
Remove - Pending Acceptance
06/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2025
06/26/2025
IVTT
600mg
Every 6hrs
Cellulitis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: